Investment
Features
FeesSafety
Academy
More
Pluang+

Pfizer stock offers 13.8% upside plus a 5.91% dividend amid strong pipeline and cost savings.

Analyst Insights
07 Sep 2026
24/7 Wall Street
View Source
Bullish
Pfizer stock offers 13.8% upside plus a 5.91% dividend amid strong pipeline and cost savings.

Pfizer shares trade at $28.77 with a 5.91% dividend yield and a 12-month price target of $32.72, implying 13.84% upside. The company reported strong Q2 2026 results, raised revenue guidance, and has a promising pipeline including Padcev and Metsera obesity assets. Cost savings of $9.7 billion through 2029 and multiple regulatory milestones support growth potential. Risks include generic competition and reduced COVID-related revenue, but heavy R&D investment backs future growth. Pfizer trades at a discount compared to peers Merck and Bristol-Myers, making it a compelling buy for investors seeking income and growth.

More News (PFE)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App